UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 263

Sortiert nach

Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity

Journal of clinical oncology, 1998-01, Vol.16 (1), p.197-203

1998

Volltextzugriff (PDF)

A Randomized Phase II Trial of Thalidomide, an Angiogenesis Inhibitor, in Patients with Androgen-independent Prostate Cancer

Clinical cancer research, 2001-07, Vol.7 (7), p.1888-1893

2001

Volltextzugriff (PDF)

Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms

Journal of clinical oncology, 1998-09, Vol.16 (9), p.2986-2999

1998

Volltextzugriff (PDF)

Factors Associated With Response to High-Dose Interleukin-2 in Patients With Metastatic Melanoma

Journal of clinical oncology, 2001-08, Vol.19 (15), p.3477-3482

2001

Volltextzugriff (PDF)

Activity of Thalidomide in AIDS-Related Kaposi’s Sarcoma

Journal of clinical oncology, 2000-07, Vol.18 (13), p.2593-2602

2000

Volltextzugriff (PDF)

Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin-2 and Interferon Alfa-2b

Journal of clinical oncology, 1999-03, Vol.17 (3), p.968-975

1999

Volltextzugriff (PDF)

Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma

Journal of clinical oncology, 1998-03, Vol.16 (3), p.1112-1121

1998

Volltextzugriff (PDF)

Phase I Clinical Trial of Oral COL-3, a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer

Journal of clinical oncology, 2001-01, Vol.19 (2), p.584-592

2001

Volltextzugriff (PDF)

A Phase II Study of High-Dose Tamoxifen in Patients with Hormone-refractory Prostate Cancer

Clinical cancer research, 1999-09, Vol.5 (9), p.2366-2373

1999

Volltextzugriff (PDF)

Clinical Trial Designs for the Early Clinical Development of Therapeutic Cancer Vaccines

Journal of clinical oncology, 2001-03, Vol.19 (6), p.1848-1854

2001

Volltextzugriff (PDF)

A Phase I Study of Combination Therapy with Immunotoxins IgG-HD37-Deglycosylated Ricin A Chain (dgA) and IgG-RFB4-dgA (Combotox) in Patients with Refractory CD19(+), CD22(+) B Cell Lymphoma

Clinical cancer research, 2000-04, Vol.6 (4), p.1302-1313

2000

Volltextzugriff (PDF)

EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma

Journal of clinical oncology, 1993-08, Vol.11 (8), p.1573-1582

1993

Volltextzugriff (PDF)

Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine

Journal of clinical oncology, 1996-03, Vol.14 (3), p.806-813

1996

Volltextzugriff (PDF)

In vitro predictors of therapeutic response in melanoma patients receiving tumor-infiltrating lymphocytes and interleukin-2

Journal of clinical oncology, 1994-07, Vol.12 (7), p.1475-1483

1994

Volltextzugriff (PDF)

Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion

Journal of clinical oncology, 1994-08, Vol.12 (8), p.1621-1629

1994

Volltextzugriff (PDF)

Controlled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapy

Journal of clinical oncology, 1995-08, Vol.13 (8), p.1995-2004

1995

Volltextzugriff (PDF)

Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer

Journal of clinical oncology, 1994-10, Vol.12 (10), p.2022-2034

1994

Volltextzugriff (PDF)

Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma

Journal of clinical oncology, 1993-10, Vol.11 (10), p.1911-1918

1993

Volltextzugriff (PDF)

Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem

Journal of clinical oncology, 1995-01, Vol.13 (1), p.165-176

1995

Volltextzugriff (PDF)

MUC1 is a novel marker for the type II pneumocyte lineage during lung carcinogenesis

Cancer research (Chicago, Ill.), 1998-12, Vol.58 (23), p.5582-5589

1998

Volltextzugriff (PDF)

Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer

Journal of clinical oncology, 1989-07, Vol.7 (7), p.890-899

1989

Volltextzugriff (PDF)

Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors

Cancer, 1996-08, Vol.78 (4), p.901-911

1996

Volltextzugriff (PDF)

Altered cJUN expression : an early event in human lung carcinogenesis

Cancer research (Chicago, Ill.), 1996-01, Vol.56 (2), p.305-315

1996

Volltextzugriff (PDF)

Expansion of the Ki‐67 proliferative compartment correlates with degree of Dysplasia in Barrett's esophagus

Cancer, 1995-01, Vol.75 (2), p.423-429

1995

Volltextzugriff (PDF)

Phase I and pharmacokinetic study of the multidrug resistance modulator dexverapamil with EPOCH chemotherapy

Journal of clinical oncology, 1995-08, Vol.13 (8), p.1985-1994

1995

Volltextzugriff (PDF)

1 – 25 von 263

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SeriePhysical Review Letters

KollektionSingle Journals

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(263)
Mit Volltextzugriff
(258)

Publikationsform

Artikel
(263)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(254)
Science & Technology
(254)
Humans
(242)
Biological And Medical Sciences
(162)
Medical Sciences
(162)
Female
(161)
Middle Aged
(159)
Male
(143)
Adult
(141)
Aged
(130)
Pharmacology. Drug Treatments
(98)
Antineoplastic Agents
(95)
Tumors
(79)
Treatment Outcome
(59)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(53)
Adolescent
(40)
Aged, 80 And Over
(38)
Chemotherapy
(38)
Drug Administration Schedule
(31)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity

A Randomized Phase II Trial of Thalidomide, an Angiogenesis Inhibitor, in Patients with Androgen-independent Prostate Cancer

Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms

Factors Associated With Response to High-Dose Interleukin-2 in Patients With Metastatic Melanoma

Activity of Thalidomide in AIDS-Related Kaposi’s Sarcoma

Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin-2 and Interferon Alfa-2b

Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma

Phase I Clinical Trial of Oral COL-3, a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer

A Phase II Study of High-Dose Tamoxifen in Patients with Hormone-refractory Prostate Cancer

Clinical Trial Designs for the Early Clinical Development of Therapeutic Cancer Vaccines

A Phase I Study of Combination Therapy with Immunotoxins IgG-HD37-Deglycosylated Ricin A Chain (dgA) and IgG-RFB4-dgA (Combotox) in Patients with Refractory CD19(+), CD22(+) B Cell Lymphoma

EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma

Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine

In vitro predictors of therapeutic response in melanoma patients receiving tumor-infiltrating lymphocytes and interleukin-2

Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion

Controlled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapy

Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer

Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma

Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem

MUC1 is a novel marker for the type II pneumocyte lineage during lung carcinogenesis

Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer

Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors

Altered cJUN expression : an early event in human lung carcinogenesis

Expansion of the Ki‐67 proliferative compartment correlates with degree of Dysplasia in Barrett's esophagus

Phase I and pharmacokinetic study of the multidrug resistance modulator dexverapamil with EPOCH chemotherapy

Aktive Filter

Suchergebnisse filtern